Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany talks about the analysis of the projects that are underway at the German CLL Study Group (GCLLSG) at the 2016 International Workshop of the GCLLSG in Cologne, Germany. Dr Bahlo explains that there is a lot of analysis to do; for example there are Phase III trials that are being analysed, there is the data for the CLLM1 trial (NCT01556776), which is being prepared for publication and further, they have a publication on minimal residual disease (MRD) in combination with response to treatment.
Current projects at the German CLL Study Group
